Reinnervation by the contralateral facial nerve in patients with peripheral facial palsy

2011 ◽  
Vol 44 (6) ◽  
pp. 923-929 ◽  
Author(s):  
Jordi Casanova-Molla ◽  
Luci León ◽  
Carlos David Castillo ◽  
Josep Valls-Solé
1989 ◽  
Vol 103 (1) ◽  
pp. 117-119 ◽  
Author(s):  
N. Stahl ◽  
T. Ferit

AbstractFacial nerve paralysis is a common otolaryngological diagnosis. Recurrent unilateral peripheral facial palsy is found in about 7 per cent of the cases. Simultaneous bilateral facial palsy is relatively uncommon and occurs in 0.3–2.0 per cent of cases of facial palsy. Recurrent. simultaneous, bilateral, idiopathic facial palsy to the best of our knowledge has never been reported. A case of recurrent, simultaneous, bilateral, idiopathic facial palsy is presented. No evidence of systemic or local disease was found in both attacks of peripheral facial palsies. The association with states of stress is the only common finding between the two attacks.


Author(s):  
Mildren Baeza Castillo ◽  
Rodrigo Quivira ◽  
Cristian Bersezio Miranda

Peripheral Facial Palsy is a neurological disorder that has motor and sensory consequences and affects the facial nerve. It causes alterations in the action of the muscles of the face, in the secretion of saliva, tears, and in the sense of taste. The objective of this publication is to report a case in which a treatment with minimally invasive combined therapies was performed together with the use of low-level laser therapy, in a 52-yearold female patient. With relevant medical history, referred for aesthetic evaluation and with unresolved moderate facial paralysis. She was subjected to laser therapy with wavelength (808 nm) and an energy of 3 Joules per session on the affected side, supplemented with Botulinum Toxin Type A, on the healthy side. The treatment of peripheral facial paralysis with minimally invasive combined therapies has proven to be a useful therapeutic tool for facial sequelae. In turn, low-level laser photobiomodulation therapy is promising as an adjunct in the nerve repair process, which would allow functional recovery of the facial nerve in the medium and long term.


1994 ◽  
Vol 108 (8) ◽  
pp. 676-678 ◽  
Author(s):  
Yoshiharu Watanabe ◽  
Minoru Ikeda ◽  
Nobuo Kukimoto ◽  
Mutsumi Kuga ◽  
Hiroshi Tomita

AbstractWe examined a very unusual patient who developed peripheral facial palsy with chickenpox. A survey of the English literature revealed that eight such patients had been reported, but the period between the appearance of the vesicles of varicella and the facial nerve palsy ranged from five days before to 16 days after the eruption development. We presume that the route of infection was neurogenous in patients who had palsy after the appearance of the eruptions, but haematogenous in patients who had palsy before the appearance of vesicles. The two patients whose infection route was presumed to be haematogenous, had a poor prognosis.


2020 ◽  
pp. 10.1212/CPJ.0000000000001020
Author(s):  
Jacqueline J Greene ◽  
Reza Sadjadi ◽  
Nate Jowett ◽  
Tessa Hadlock

AbstractObjectives:Slow-onset peripheral facial palsy is far less common than acute-onset peripheral facial palsy and necessitates diagnostic evaluation for a benign or malignant tumors, or other less common etiologies. In the rare scenario when no clarifying etiology is discovered following long-term evaluation (no radiographic or hematologic abnormalities and an otherwise unremarkable evaluation), a diagnostic and management dilemma occurs. We present a series of patients with this possible new clinical entity: facial palsy, radiographic and other workup negative (FROWN), and propose a management strategy for this diagnosis of exclusion.Methods:A series of 3,849 patients presenting with facial palsy to a tertiary Facial Nerve Center was retrospectively assessed to identify those with progressive loss of facial function over at least 1 month. Exclusion criteria included history, physical or hematologic findings indicative of known diseases associated with facial palsy, and radiographic studies demonstrating a benign or malignant tumor.Results:Patients with slow-onset facial palsy constituted 5% (190 patients) of the cohort and were ultimately diagnosed with either a benign or malignant neoplasm or other facial nerve pathology. Fourteen patients with slow-onset facial palsy remained without a diagnosis following long-term evaluation and serial imaging. Eleven patients underwent dynamic facial reanimation surgery and facial nerve and muscle biopsy, with no clear histopathologic diagnosis.Conclusion:Patients with slow-onset facial palsy with negative radiographic and medical evaluations over several years may be characterized as having FROWN, an idiopathic and as yet poorly understood condition, which appears to be amenable to facial reanimation, but which requires further investigation as to its pathophysiology.


2009 ◽  
Vol 120 (1) ◽  
pp. e59
Author(s):  
U. Dillmann ◽  
J. Spiegel ◽  
M. Marziniak ◽  
J. Koenig ◽  
C. Chelius ◽  
...  

2021 ◽  
Vol 114 (10) ◽  
pp. 753-758
Author(s):  
Yoshihiko Kumai ◽  
Momoko Ise ◽  
Yorihisa Orita

2020 ◽  
Vol 13 (8) ◽  
pp. e237146
Author(s):  
Rita Figueiredo ◽  
Vera Falcão ◽  
Maria João Pinto ◽  
Carla Ramalho

Acute facial nerve disease leading to peripheral facial paralysis is commonly associated with viral infections. COVID-19 may be a potential cause of peripheral facial paralysis and neurological symptoms could be the first and only manifestation of the disease. We report a case of a term pregnancy diagnosed with COVID-19 after presenting with isolated peripheral facial palsy.


2013 ◽  
Vol 30 (5) ◽  
pp. 155-167 ◽  
Author(s):  
Pil Kun Kim ◽  
Won Suk Sung ◽  
Bon Hyuk Goo ◽  
Hee Kyung Ryu ◽  
Kyung Hwan Suk ◽  
...  

2008 ◽  
Vol 39 (01) ◽  
Author(s):  
U Dillmann ◽  
J Spiegel ◽  
M Marziniak ◽  
J Koenig ◽  
C Chelius ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document